Free Cash Flow Operating Cash Flow 23,536,000 15,193,000 6,810,000 3,358,000 23,416,000 Capital Expenditure -3,347,000 -2,024,000 -1,287,000 -625,000 -3,498,000 Free Cash Flow 20,189,000 13,169,000 5,523,000 2,733,000 19,918,000 Back...
most recent quarter $180,104 cash flow total operating cash flow per share, avg. diluted shares outstanding, ttm 10.00 free cash flow - trailing 12 month $8,019 dividend dividends per share - trailing 12 month 4.91 dividend rate, indicated annual 4.96 price volume beta 0.49 volume - avg. ...
5-Year free cash flow returned to shareholders >65% Of sales come from #1 or #2 global market share position 2023 Investor fact sheet Investor news See all investor news Events and presentations See all investor events Learn more about quarterly results Innovative Medicine pipeline Learn mor...
Thank you, Jessica, and hello, everyone. Thank you for joining today's call. Overall, Johnson & Johnson delivered solid top and bottom line, as well as free cash flow growth in the quarter. Our Innovative Medicines business made great progress in the second quarter. ...
Let’s now turn to cash and capital allocation. We ended the third quarter with approximately $24 billion of cash and marketable securities and approximately $30 billion of debt for a net debt position of $6 billion. Free cash flow year-to-date through the third quarter was approximately $...
That’s understandable when we consider JNJ’s net cash position (over $12 billion), its very strong current ratio (short-term assets/short-term liabilities), and the enormous amount of free cash flow it generates. And when we compare Johnson & Johnson’s credit metrics against those of its...
EPV Adjusted Earnings - A measure of free cash flow made famous by Columbia University Professor Bruce Greenwald. Adjusted earnings is calculated by estimating a "sustainable" level of revenues and profits based on historical trends. Change In Income Taxes - Changes in income tax accounts Adjusted ...
This isn’t a big deal for the company. Johnson & Johnson has a 12-month trailingfree cash flow of $17.4 billion. Its net debt of $11.3 billion is just 2.8% of its market cap. Momenta is a rounding error. According to a recent article inForbes,immunology accoun...
Free Cash Flow / Share (TTM) $7.50 Full Cash Flow Statement » JNJ:CA Long Term Solvency Total Debt / Equity (MRQ) 52.92% Total Debt / Capital (MRQ) 34.61% LT Debt / Equity (MRQ) 44.55% LT Debt / Total Capital (MRQ) 29.13% Total Liabilities / Total Assets (MRQ) 60.31% Discover...
Ops 5.55% -7.55% -1.43% -1.48% EPS (Diluted) -57.81% -9.50% 0.56% 0.16% Tangible Book Value NM NM NM NM Total Assets 7.49% -0.35% 2.69% 3.29% Levered Free Cash Flow -16.31% 1.86% -7.64% -1.29%People Also Follow SymbolLast PriceChange PGThe Procter & Gamble Company 167.97 Post....